ProVen Growth & Income VCT Plc

ProVen Growth & Income VCT Plc (PGI VCT) is venture capital trust that invests in a diversified portfolio of UK based unquoted companies. The companies are selected by the Manager as having, in its opinion, significant potential for growth.

Call Beringea on 020 7845 7820 for more information.

INVESTMENT OBJECTIVES

  • Achieve a total return significantly greater than that available from direct investment in quoted businesses by investing in a portfolio of carefully selected small and medium sized companies with excellent growth prospects;
  • Minimise the risk of each investment and the portfolio as a whole; and
  • Obtain and maintain VCT status in order to secure the substantial tax benefits available for investment in a VCT.

INVESTMENT STRATEGY

PGI  VCT seeks to make investments in VCT qualifying companies with the following characteristics:

  • a strong, balanced and well motivated management team with a proven track record of achievement and a substantial shareholding in the business;
  • a defensible market position;
  • good growth potential;
  • an attractive entry price for the Company;
  • the ability to structure the investment with a proportion of secured loan notes in order to reduce risk;
  • a clearly identified route for a profitable realisation within a 3-4 year period.

PGI VCT invests in companies at various stages of development, including those requiring capital for expansion and management buyouts, but not in start-ups. Investments are spread across a range of different sectors.

After it has invested in a business the manager, Beringea, remains closely involved, adding value wherever possible. As the values of the investments increase, Beringea aims to identify opportunities for profitable realisations. Capital gains made on disposals of the investments are not subject to tax and are distributed to shareholders in PGI VCT as tax-free dividends. (See About VCTs section for more info on tax).

FOR FURTHER INFORMATION CLICK/TAP BELOW

  • TOP 10 INVESTMENTS
    Third Bridge
    Third Bridge

    Third Bridge offers a broad range of research services to private equity firms, hedge funds, asset managers and large consulting businesses.

    www.thirdbridge.com/
    Pulpitum Limited
    Pulpitum Limited

    Pulpitum Limited is an acquisition platform company, established with the objective of trading as a digital company, which will look to acquire attractive businesses within the digital sector.

    APM Healthcare Limited
    APM Healthcare Limited

    APM Healthcare, through its subsidiary Community Pharmacies (UK) Limited, is aiming to become a prominent niche player in the prescription pharmacy sector.

    www.apmhealthcare.co.uk
    SwitchMyBusiness
    SwitchMyBusiness
    SwitchMyBusiness is an energy price comparison and brokerage service aimed primarily at Small and Medium Businesses in the UK.  www.switchmybusiness.com/
    Maplin
    Maplin

    Maplin Electronics is the UK’s biggest and best specialist retailer of consumer electronics. Its national network of stores are a goldmine of useful consumer technologies and gadgets. With over 15,000 different products Maplin Electronics sells everything from MP3 players and Sat Nav systems, to digital cameras ad Wi-Fi connectors, across the broad categories of Sound & Vision, Computer, and Hobbies & Electronics.

    www.maplin.co.uk/
    Abzena
    Abzena

    Abzena provides a suite of complementary services and technologies to R&D organisations to improve the chances of successful development of therapeutic proteins and antibodies and is therefore poised to capitalise on the growth of the biopharmaceutical market. Abzena has significant know-how, supported by a broad patent estate, to enable it to create better biopharmaceuticals for its customers.

    www.abzena.com
    Inskin Media Limited
    Inskin Media Limited

    Inskin Media is a UK-based company that has developed a range of technologies for the rapidly growing area of online video advertising.

    www.inskinmedia.com
    Monica Vinader Limited
    Monica Vinader Limited

    Monica Vinader is an award‐winning high‐end fashion jewellery brand. The elegant vibrant collections, which have been showcased across the UK, Europe, Japan and U.S., focus predominately on gold, silver and semi‐precious stones and have demonstrated broad appeal amongst customers, celebrity clients and the fashion press.

    www.monicavinader.com
  • DIVIDENDS

    PGI VCT has a target dividend yield of approx. 5% of Net Asset Value (NAV) per year. The VCT may pay a special dividend in addition to this, in the event of there being a realistion from the portfolio which results in an exceptionally large gain. The objective of paying a dividend of approx 5% of NAV each year is a target and there is no guarantee at this will be achieved.

    The latest performance information is as follows. A Historical Dividend document can be download below. Please note: This historical dividend document shows how PGI VCT has performed historically. However, past performance is no guide to future performance.

    Download Historical Dividends Document
  • DIRECTORS

    Marc VlessingChairman - PGI VCT

    Marc Vlessing

    Natasha Christie-Miller Director- PGI VCT

    Natasha Christie-Miller

    Malcolm MossDirector

    Malcolm Moss

    James StewartDirector - PGI VCT

    James Stewart

    Marc Vlessing

    Marc Vlessing

    Marc Vlessing

    Chairman - PGI VCT

    Email: Marc Vlessing

    Marc started his career as a corporate financier with County NatWest where he became an Associate Director. In 1991, he set up a management consultancy business specialising in the media sector. In 1997, he became Chief Executive of the theatre, cinema and TV group Crescent Entertainment, which he managed towards a successful sale. He subsequently became Chief Executive of First Call International. He is a founder Director and CEO of Pocket, London's first private developer that focuses exclusively on delivering intermediate housing for the starter market. The company (see: www.pocketliving.com) has delivered schemes across London and was awarded a £21.7m equity loan for 10 years by the Mayor of London as part of his Housing Covenant commitment to help thousands of working Londoners into home ownership.

    ×

    Natasha Christie-Miller

    Natasha Christie-Miller

    Natasha Christie-Miller

    Director- PGI VCT

    Email: Natasha Christie-Miller

    Natasha has worked in the media sector for 21 years. For the last 15 years she has been at EMAP, recently rebranded as Top Right Group plc. At EMAP Natasha has worked on a wide range of magazine titles such as Elle, Red and Heat and became MD of EMAP's B2B Retail division in 2007. In 2010, Natasha became CEO of EMAP a subscriptions and content business. Natasha joined the Board of ProVen Growth & Income VCT as a non-executive director in 2011.

    ×

    Malcolm Moss

    Malcolm Moss

    Malcolm Moss

    Director

    Email: Malcolm Moss

    Malcolm is a Founding Partner of Beringea. Over the last 20 years he has been responsible for the growth, development and management of the private equity business of Beringea in both the UK and the USA.

    In addition to sitting on the boards of ProVen VCT plc, ProVen Growth & Income VCT plc and ProVen Planned Exit VCT plc, he sits on the investment committees of Beringea’s three other venture capital funds and as a non-executive director on several portfolio company boards. 

Prior to founding Beringea, Malcolm gained Europe-wide industrial, planning and analytical experience in healthcare, engineering and financial services with Baxter International, Uniroyal Inc. and Lloyds TSB Group. Malcolm has a MBA from Kingston Business School and a degree in Business Studies.


    ×

    James Stewart

    James Stewart

    James Stewart

    Director - PGI VCT

    Email: James Stewart

    James was formerly managing director of Creditanstalt Investment Bank AG’s subsidiary in London, where he had previously established Creditanstalt Bankverein’s development capital activity. He has been a non-executive director of a number of quoted and unquoted companies and he now works as an independent venture capitalist.

    ×
  • SELLING SHARES

    Shares in a VCT can be bought and sold on the London Stock Exchange via a stockbroker. There is, however, likely to be a very limited secondary market for shares. Investors are reminded that there may be tax implications in respect to selling VCT shares and are therefore advised to consult their independent financial adviser if they have any queries.

    Shareholders considering selling their shares, or trading in the secondary market, should contact the Company's Corporate Broker, Panmure Gordon (UK) Limited.

    Panmure Gordon Ltd is able to provide details of close periods (when the company is prohibited from buying shares) and details of the price at which the VCT has bought in shares. They can be contacted as follows:

    Chris Lloyd: 0207 886 2716
 Chris.lloyd@panmure.com

    Paul Nolan: 0207 886 2717
 Paul.nolan@panmure.com

    Buy Back Policy

    PGI VCT has a policy of buying back shares at a discount of 5% to the last published net asset value adjusted for any dividends subsequently paid, subject to there being sufficient liquidity and the respective VCT not being in a "close period" (i.e. in the period prior to the announcement of the full year and half year results).

    As the VCTs are unable to buy back shares directly from Shareholders, a stockbroker will need to be appointed to sell the shares. 

    Please call Beringea for further information on 020 7845 7820.

    IMPORTANT NOTE: Selling shares less than 5 years from subscription will result in the shareholder having to repay the initial tax relief.

  • HISTORICAL INFORMATION

    Historic Mergers

    The Company first launched an offer for ordinary shares in February 2001, an offer for C shares in November 2005 and an offer for D shares in November 2008. Additional fundraisings on both the ordinary shares and D shares took place subsequent to the initial offers.

    The ordinary shares in existence today were created from the consolidation of the original ordinary shares and C shares in October 2009. One original ordinary shares converted into approximately 0.6178 ordinary shares and one original C share converted into one ordinary share. In October 2012, the D shares were converted into new ordinary shares; D shareholders received approximately 1.1427 new ordinary shares for each D share held.

    ProVen Health VCT

    On 6th August 2013, ProVen Health VCT (PHV) merged with ProVen Growth & Income VCT. Shareholders received approximately 0.3614 ordinary shares in PGI for each PHV share previously held (rounded down to the nearest whole share). New PGI share certificates were issued to former PHV shareholders and these replace existing PHV share certificates.

  • CORPORATE GOVERNANCE

    AGM results are available here

    Recent corporate governance documents - comprising Audit Committee Terms of Reference, Nomination Committee Terms of Reference, Anti Bribery Policy and Remuneration Committee Terms of Reference - are available in the literature section of the website click here.

    ProVen Growth & Income VCT plc is registered in England & Wales under registered number 4125326.  The Company's registered office is 39 Earlham Street, London WC2H 9LT.

    As at 30 April 2017 the Company's issued share capital comprised 137,244,476 Ordinary shares.  The total number of voting rights in the Company as at 30 April 2017 is, therefore 137,244,476.

Returns Illustrator - More info

No account has been taken of the possible benefit of any capital gains tax deferral (available for new investments up to and including tax year 2003/2004) or of additional shares that may have been available through early bird or financial intermediary discounts. The analysis assumes that 'C' Shareholders did not take part in the 'C' Share tender offer in August 2012; for those 'C' Shareholders who did take part, the total return would remain unchanged but the shareholder would have received an additional distribution offset by a reduced NAV.

×

Net Cost

Net cost with initial income tax relief, dividends received, current valuation and total return are shown per £1 invested, excluding impact of discounts on subscription, reinvested initial commission, tender offers and enhanced share buybacks.

×

Dividends

Calculated as: Dividends per Share x 100/Subscription Price - as at 30 November 2016.

×

Current Value

Calculated as: Current NAV per Share x 100/Subscription Price- as at 30 November 2016.

×

Note

Ordinary Shares issued to former Proven Health VCT Plc shareholders have now been converted to ProVen Growth & Income VCT shares.

×

Note

ALL C AND D SHARES HAVE NOW BEEN CONVERTED TO ORDINARY SHARES. The Company first launched an offer for ordinary shares in February 2001, an offer for C shares in November 2005 and an offer for D shares in November 2008. Additional fundraisings on both the ordinary shares and D shares took place subsequent to the initial offers. The ordinary shares in existence today were created from the consolidation of the original ordinary shares and C shares in October 2009. One original ordinary shares converted into approximately 0.6178 ordinary shares and one original C share converted into one ordinary share. In October 2012, the D shares were converted into new ordinary shares; D shareholders received approximately 1.1427 new ordinary shares for each D share held. The net asset value per new ordinary share at 30 November 2012 was 80.1p

×

Note

×

Terms of Use

Please read the following terms of use for this website then click on the link above to confirm acceptance:

Regulatory Information

The ProVen VCTs are managed by Beringea LLP, a specialist private equity fund manager based in the UK which is authorised and regulated by the Financial Conduct Authority (FCA). Beringea LLP's FCA Firm Reference Number is 496358.

The market price of VCT shares may not reflect the full underlying net asset value ("NAV") of shares and shareholders may have dificulty in selling their shares and any sale is likely to be at a discount to the NAV.

The value of shares in a VCT and the income from them may fluctuate and investors may not get back the amount they invested. The market price of VCT shares is unlikely fully to reflect their underlying net asset value. It is possible that there may not be a liquid market in the shares of VCTs and shareholders may have difficulty in selling their shares. Any sale is likely to be at a discount to net asset value.

VCTs invest in a portfolio of small companies, which by their nature carry greater risk than larger, quoted companies.

Due to a number of the features and risk factors associated with VCTs, it is an investment that is more appropriate for HNWs/Sophisticated Investors.

To comply with the requirements of the Data Protection Act 1998, we adhere to strict security procedures and have taken all measures.

A copy of these Terms of Use can be found in the Legal and Privacy section of this website.